The Eyes Have It: Optimizing the Treatment of AMD and DME (Enduring)

David Boyer, MD, is a partner with Retinal-Vitreous Associates Medical Group in Los Angeles and Clinical Associate Professor at the University of Southern California. After graduating from the Chicago Medical School, he completed his ophthalmology residency at USC County Medical Center in Los Angeles and a fellowship at Wills Eye Hospital in Philadelphia. Dr. Boyer is a past recipient of the Jules Stein Living Tribute award and the Honor Award from the American Academy of Ophthalmology Board of Trustees. Over the past three decades, Dr. Boyer has presented numerous abstracts and invited lectures at various national and international symposia. He has authored a number of scientific papers and a medical text chapter, and is currently an investigator for several clinical trials.

Michael S. Ip, MD, is Associate Professor, Department of Ophthalmology and Visual Sciences, and Co-Director of the Fundus Photograph Reading Center at the University of Wisconsin Medical School in Madison. He serves as Director of Retina Service at William S. Middleton Memorial Veterans Hospital in Madison. He also has an active clinical practice as a vitreoretinal surgeon that concentrates on the surgical management of retinal detachment and other conditions as well as the treatment of age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and other conditions. Dr Ip received his medical degree from New York University and completed his internship at Lenox Hill Hospital, both in New York, New York. He completed his residency at the University of Pittsburgh School of Medicine in Pennsylvania followed by a fellowship in vitreoretinal surgery at New England Eye Center, Tufts University, in Boston, Massachusetts.

 

Dr Ip’s research focuses on the design and conduct of clinical trials investigating treatments for diabetic retinopathy, age-related macular degeneration, and retinal venous occlusive disease. As Co-Director of the Fundus Photograph Reading Center, he has assisted with the collection, analysis, and dissemination of important secondary outcomes in ophthalmic clinical trials, such as the Eli Lilly trials for protein kinase C inhibitor for diabetic macular edema (MBBK), the transpupillary thermotherapy of occult subfoveal choroidal neovascular membranes in patients with age-related macular degeneration trial (TTT4CNV), the Control Delivery Systems trials evaluating intravitreal fluocinolone implants, and the Bausch & Lomb trials investigating fluocinolone acetonide intravitreal implant. As a clinical site investigator, he has served as the Principal Investigator on 10 clinical trials. He has also served as a protocol chair for the clinical trial conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema and as the National Principal Investigator for the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study. Dr Ip received an award from the National Eye Institute, National Institutes of Health in 2003 to conduct the SCORE study. He has authored more than 40 peer-reviewed articles, 19 book chapters, and more than 30 abstracts on these topics as well as given many national and international presentations. Dr Ip is also a reviewer for the following five journals: Ophthalmic Surgery and Lasers, Investigative Ophthalmology and Visual Science, American Journal of Ophthalmology, Retina, and Ophthalmology. He is currently an Associate Editor for Archives of Ophthalmology. In addition, he serves on a variety of committees in the American Academy of Ophthalmology, including the Ophthalmology Technology Assessment Committee and Curriculum Development Committee (COMPASS), and is a member of the Food and Drug Administration Panel on Orphan Drug Development. Dr Ip has been recognized with several honors, including the Achievement Award and the Leadership Development Program Award, both from the American Academy of Ophthalmology.